May 29, 2019
Rose
Patients who are undergoing immunotherapy are developing a disease akin to type 1 diabetes. “If I knew then, when I opted for the clinical trial, what type 1 diabetes entailed, I would never have gone for the immunotherapy. Never. I would have taken the chance of the cancer coming back,” said Jaime Vidal, 79, a retired mailman from San Bruno, Calif. In other pharmaceutical news: accelerated approvals for cancer drugs, troubling manufacturing problems and the right-to-try bill.
from Kaiser Health News http://bit.ly/2VXASec
May 29, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
NIH Needs To Look At Price Tags Of Drugs Created Using Taxpayer Money, Advocates Say- Viewpoints: Criminalizing Relapses During Opioid Epidemic Is Absurd; Chipping Away At ACA Threatens Mental Health Care
Watch: Beyond Puerto Rico’s Grim Statistics, Stories Of Lives And Deaths- State Highlights: Differences Over Homeless Crisis Emerge In San Francisco’s Mayoral Race; Missouri Designates Certain Hospitals As Best For Heart Attack Care
- Perspectives: Drug Companies Placing Higher Priority On Profits Than The Lives They Could Be Saving
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment